FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

1312811000001105: Mesalazine 500mg suppositories 30 suppository (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22587301000001116 Mesalazine 500mg suppositories 30 suppository (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22587401000001112 Mesalazine 500mg suppositories 30 suppository en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mesalazine 500mg suppositories 30 suppository Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories 30 suppository Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories 30 suppository Is pack of Product containing precisely mesalazine 500 milligram/1 each conventional release rectal suppository false Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories 30 suppository Has active ingredient Mesalazine false Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories 30 suppository VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories 30 suppository VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories 30 suppository Has manufactured dose form Suppository false Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories 30 suppository Has VMP Product containing precisely mesalazine 500 milligram/1 each conventional release rectal suppository true Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories 30 suppository Has specific active ingredient Mesalazine true Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories 30 suppository Has dispensed dose form Suppository true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Salofalk 500mg suppositories (Dr Falk Pharma UK Ltd) 30 suppository 6 x 5 suppositories Is a True Mesalazine 500mg suppositories 30 suppository Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start